mcp 60 seconds with dr lauren dalvin on tnf-alpha inhibition
Published 5 years ago • 492 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
0:56
mcp 60 seconds with dr lauren wallner on prostate cancer mortality
-
1:14
mcp 60 seconds with dr tait shanafelt on imposter phenomenon
-
1:01
mcp 60 seconds with drs minor and shanafelt on physcian wellness
-
1:01
mcp 60 seconds with drs ruano, klinkner, & mccauley on fetoscopic therapy
-
4:16
immunosuppressants in the development of melanoma
-
1:07
mcp 60 seconds with ms dalene m. bott kitslaar on vte
-
1:07
mcp 60 seconds with drs cohen & knox on pain in covid-19
-
1:11
mcp 60 seconds with drs allen & couser on psychiatric disorders
-
8:14
understanding the persistent symptoms in lyme disease | johns hopkins medicine
-
3:54
typical diagnostic journey for follicular lymphoma patients
-
21:24
cell surface markers: cd3, cd4, cd8, cd19, cd28, cd16, cd56
-
0:45
car t-cell therapy in lenalidomide-refractory multiple myeloma
-
0:27
copy of dr. flinn on the relevance trial in follicular lymphoma
-
2:39
ifn-beta-1a for preventing toxicities after cd19-directed car t-cell therapy: a trial in progress
-
4:06
single-agent lenalidomide maintenance after upfront autosct in newly diagnosed multiple myeloma
-
0:54
dr. flinn discusses the dynamo trial
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
1:18
dr. batlevi on challenges faced in follicular lymphoma management
-
1:43
ongoing clinical trials to look out for in lymphoma
-
1:08
bretuximab vedotin plus re-induction chemotherapy for cd30 r/r aml
-
1:01
teflon granuloma and mvd (preview)
-
1:38
foll12 trial: response-oriented maintenance therapy for advanced follicular lymphoma